Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

por Minting Chen, Keying Zhong, Jincheng Tan, Mingjing Meng, Chok Mei Liu, Baisen Chen, Chunhua Huang, Hoi Leong Xavier Wong, Zhaoxiang Bian, Tao Su, Hiu Yee Kwan
Publicado 2021